Arkolith/Insider Trading/GLUE/Form 4

Leo Chandra P.

DirectorMonte Rosa Therapeutics, Inc. (GLUE) · full profile →Form 4 · filed Mar 25, 2025
Net Buying
Open-Market Buys
$58K
Open-Market Sells
$0
Net Open-Market Flow
$58K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2025Buy(P)10K$5.84$58K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-044633) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML